Pharmacokinetics of the novel oral prostacyclin receptor agonist selexipag in subjects with hepatic or renal impairment

類似資料

• Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects
  著者:: Kaufmann, Priska, 等
  出版事項: (2015)
• Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag
  著者:: Kaufmann, Priska, 等
  出版事項: (2015)
• Effect of gemfibrozil and rifampicin on the pharmacokinetics of selexipag and its active metabolite in healthy subjects
  著者:: Bruderer, Shirin, 等
  出版事項: (2017)
• A thorough QT study in the context of an uptitration regimen with selexipag, a selective oral prostacyclin receptor agonist
  著者:: Hoch, Matthias, 等
  出版事項: (2014)
• Integrated pharmacokinetics and pharmacodynamics of epoprostenol in healthy subjects
  著者:: Nicolas, Laurent B, 等
  出版事項: (2012)